Serum Market Report 2025

The serum market size has grown rapidly in recent years. It will grow from $1.42 billion in 2024 to $1.57 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to medical diagnostics, clinical research, drug development and testing, disease monitoring, therapeutic applications.

The serum market size is expected to see rapid growth in the next few years. It will grow to $2.37 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to precision medicine advances, rise in personalized healthcare, expanded applications in oncology, global health initiatives, increasing geriatric population. Major trends in the forecast period include adoption of customizable serum solutions, use of fermented ingredients for skin health, introduction of CBD-infused serums, application of niche ingredients such as retinol alternatives, emphasis on inclusive beauty and diverse formulations.

The growing awareness of age-related skin issues is anticipated to drive the expansion of the serum market. Age-related skin issues encompass conditions commonly experienced by older adults, such as wrinkles and facial movement lines. Serums are designed to address these concerns, treating conditions like dullness, hyperpigmentation, dehydration, and loss of firmness, while also evening out skin tone, reducing visible imperfections, and providing nourishment. For example, in July 2022, Melanoma UK, a patient support and advocacy group based in the UK, projected that by 2025, melanoma skin cancer cases would increase by 9%, reaching a total of 19,513. Additionally, fatalities from the disease are expected to rise by 13%, resulting in 3,119 deaths. By 2040, nearly 22,886 individuals are anticipated to be diagnosed with melanoma skin cancer. Thus, the heightened awareness of age-related skin issues is propelling the growth of the serum market.

The serum market is expected to witness growth due to the increasing prevalence of chronic diseases. Chronic diseases are prolonged illnesses lasting three months or more, with the potential to deteriorate over time. Serums serve as targeted solutions to manage and improve skin health for individuals dealing with dermatological effects of chronic conditions. According to the World Health Organization (WHO) 2022 Highlights in September 2022, 74% of all deaths globally were attributed to noncommunicable diseases (NCDs) or chronic diseases, resulting in 41 million deaths annually. This highlights the significant impact of chronic diseases on global health and, consequently, the growth of the serum market.

Product innovation stands out as a prominent trend in the serum market, with major companies focusing on developing innovative formulations for skincare and beauty applications. Galderma, a Switzerland-based pharmaceutical company, exemplifies this trend with the launch of HA Immerse Serum in March 2022. This product, part of ALASTIN Skincare's lineup, aims to hydrate the skin surface and enhance the skin's innate ability to produce hyaluronic acid. The serum incorporates ALASTIN's patented Octapeptide-45, contributing to long-term skin plumping, anti-aging effects, and hydration.

The key players in the serum market are concentrating on introducing cutting-edge solutions such as ultrasensitive biomarker detection to stay competitive. Ultrasensitive biomarker detection involves the ability to detect and measure biomarkers at extremely low concentrations, enabling earlier disease detection. Quanterix, a US-based company specializing in digitizing biomarker analysis, exemplifies this trend. In July 2023, Quanterix launched the LucentAD Biomarker Blood Test, designed to measure an isoform of phosphorylated tau protein in plasma, aiding in Alzheimer's disease diagnosis. This test enhances accuracy, efficiency, and collaboration with other diagnostic tools, ultimately benefiting patients and healthcare providers.

In April 2022, Anzco Foods, a New Zealand-based meat producer, acquired Moregate Biotech for an undisclosed amount. This acquisition enables Anzco Foods to expand its portfolio to include healthcare products and services. Moregate Biotech, an Australia-based manufacturer of animal serum and related products, becomes part of Anzco Foods' diversified offerings.

Major companies operating in the serum market include Merck Group, Thermo Fisher Scientific Inc., Danaher Corp, Corning Incorporated, Sartorius AG, Bio-Techne Corporation, Takara Bio Inc., Atlas Biologicals Inc., Proliant Health & Biologicals, Seracare Life Sciences Inc., Lampire Biological Labs Inc., Altogen Labs, Innovative Research Inc., Lee Biosolutions Inc., Bovogen Biologicals Pty. Ltd., Caisson Labs Inc., Gemini BioProducts Holding Inc., Valley Biomedical Products & Services Inc., Equitech-Bio Inc., Rocky Mountain Biologicals, PAN-Biotech GmbH, BIOWEST SAS, Moregate Biotech, Tissue Culture Biologicals, Kerafast Inc., Access Biologicals LLC, Animal Technologies Inc., Cell Applications Inc., Cell Sciences Inc.

North America was the largest region in the serum market in 2024. The regions covered in the serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the serum market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Serum is the clear liquid remaining after the removal of blood cells and clotting proteins. It serves as a supplement to the basal growth medium in cell culture applications.

The primary types of serum include bovine serum, fetal bovine serum (FBS), and others. Bovine serum refers to a fluid that remains after clotting in the entire blood, transparent and yellow in color. Inactivation techniques comprise heat inactivated and non-heat inactivated methods, with various applications such as biological products, research, cell culture, biopharmaceutical drugs, vaccine products, diagnostic products, and others.

The serum market research report is one of a series of new reports that provides serum market statistics, including serum industry global market size, regional shares, competitors with a serum market share, detailed serum market segments, market trends and opportunities, and any further data you may need to thrive in the serum industry. This serum market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The serum market consists of sales of specialty fetal bovine serum, newborn calf serum, and donor bovine serum. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.